Literature DB >> 6590902

[Monoclonal antibody-defined tumor marker CA19-9: evaluation of its clinical usefulness, using the radioimmunometric assay for CA19-9].

H Oguchi, T Homma, A Nagata, S Kawa, H Hirabayashi, Y Tamura, S Monno, T Shirai, K Shimakura, Y Koike.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6590902

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN： 0446-6586


× No keyword cloud information.
  2 in total

1.  Factors affecting serum levels of CA 19-9 with special reference to benign hepatobiliary and pancreatic diseases.

Authors:  N Sawabu; Y Takemori; D Toya; M Yoneshima; H Kidani; Y Satomura; H Ohta; N Hattori
Journal:  Gastroenterol Jpn       Date:  1986-10

2.  Highly elevated serum levels of CA 19-9 in choledocholithiasis: a case report.

Authors:  Georgios Marcouizos; Eleftheria Ignatiadou; Georgios E Papanikolaou; Dimosthenis Ziogas; Michail Fatouros
Journal:  Cases J       Date:  2009-07-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.